Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1958, in a Letter to the…
More Articles
New Meds and Tech from PES Drugs and Therapeutics committee The FreeStyle Libre 3 is the third generation of Abbot Laboratories’ continuous glucose monitoring system intended for day-to-day glucose monitoring…
New Meds and Tech from PES Drugs and Therapeutics committee The Omnipod 5 (Insulet Inc) is a hybrid closed-loop system approved by the FDA on January 28, 2022 for use…
Dear PES Members: As August comes to a close, many of you have children beginning a new school year. It’s a new slate, with a year of new possibilities and…
Historical Tidbit: A cautionary genetics tidbit Submitted by Walter L. Miller, MD Whole exome sequencing (WES) aims to determine the sequence of all protein-coding segments (‘exons’) in genomic DNA. As…
New Meds and Tech from PES Drugs and Therapeutics committee PES Drug Alert – GnRH agonists On July 1, 2022 the Food and Drug Administration (FDA) announced that a warning…
Hello everyone and hoping you are surviving these high temperature records. Our Canadian family members perhaps are enjoying the ambient temperatures of 75 degrees F (24 C) while it is…
History Tidbit: The adjustable micropipette Submitted by Walter Miller In our youth, many of us used glass pipettes to make buffers and other solutions. Following the introduction of the adjustable…
Kara Beliard, MD I am a 3rd-year Pediatric Endocrinology Fellow at the Kravis Children’s Hospital at Mount Sinai, NYC. My time is shared between patient care and basic science research.…
Hello to my Pedi Endo family. Now that we are in summer, I am hoping that you have some “me time.” You might be traveling for the first time in…
Update to the Vosoritide (Voxzogo TM) indication in USA On October 20, 2023 US Food and Drug Administration (FDA) has extended approval of Voxzogo to children with Achondroplasia of all…